GENERIC NAME OF THE MEDICINAL PRODUCT:
QUALITATIVE AND QUANTITATIVE COMPOSITION:
Each film coated tablet contains:
Remogliflozin Etabonate………………100mg
Vildagliptin……………………………………50mg
Metformin Hydrochloride IP…………500mg
Excipients………………………………………q.s
Colours: Ferric oxide USP-NF and
Titanium Dioxide IP
THERAPEUTIC INDICATIONS:
CAUTION & SCHEDULE:
KEEP MEDICINE OUT OF REACH OF CHILDREN.
Tablet to be swallowed as a whole, and not to be chewed or crushed.
SCHEDULE: SCHEDULE H PRESCRIPTION DRUG CAUTION: Not to be sold by retail without the prescription of a Registered Medical Practitioner.
SCHEDULE: SCHEDULE G PRESCRIPTION DRUG CAUTION: It is dangerous to take this preparation except under medical supervision.
STORAGE & DOSAGE:
Store in cool, dry & dark place.
Protect from Light & moisture.
Dosage: As directed by the Physician.
Remogliflozin Etabonate 100mg + Vildagliptin 50mg + Metformin Hydrochloride 500mg Tablets Technical Specification:
| Product Name: | Remogliflozin Etabonate 100mg + Vildagliptin 50mg+ Metformin Hydrochloride 500mg Tablets |
| Brand Name: | Generic |
| Strength: | (100mg+50mg+500mg) |
| Dosage Form: | Tablets (film-coated) |
| Route of Administration: | Via Oral Route |
| Packing: | 10 strips of 10 tablets each |
| Pack Insert/Leaflet: | PIL (Patient Information Leaflet) |
| Regulatory Documents: | COA, MOA, Stability Studies, GMP |
| Therapeutic use: | Antidiabetic |
| Indication: | This combination belongs to the group of anti-diabetic medicines used to treat type-2 diabetes mellitus. Type-2 diabetes mellitus is also known as non-insulin-dependent diabetes or adult-onset diabetes. |
| Storage: | Store below 30℃. Store in cool, dry & dark place. Protect from Light & moisture. |
GENERIC NAME OF THE MEDICINAL PRODUCT:
- Remogliflozin Etabonate 100mg + Vildagliptin 50mg+ Metformin Hydrochloride 500mg Tablets
QUALITATIVE AND QUANTITATIVE COMPOSITION:
- Remogliflozin Etabonate 100mg + Vildagliptin 50mg+ Metformin Hydrochloride 500mg Tablets
Each film coated tablet contains:
Remogliflozin Etabonate………………100mg
Vildagliptin……………………………………50mg
Metformin Hydrochloride IP…………500mg
Excipients………………………………………q.s
Colours: Ferric oxide USP-NF and
Titanium Dioxide IP
THERAPEUTIC INDICATIONS:
This combination belongs to the group of anti-diabetic medicines used to treat type-2 diabetes mellitus. Type-2 diabetes mellitus is also known as non-insulin-dependent diabetes or adult-onset diabetes.
CAUTION & SCHEDULE:
CAUTION: Read enclosed leaflet before use.
Keep medicine out of reach of children.
Tablet to be swallowed as a whole, and not to be chewed or crushed.
SCHEDULE: SCHEDULE H PRESCRIPTION DRUG CAUTION: Not to be sold by retail without the prescription of a Registered Medical Practitioner.
SCHEDULE: SCHEDULE G PRESCRIPTION DRUG CAUTION: It is dangerous to take this preparation except under medical supervision.
STORAGE & DOSAGE:
Storage: Store below 30℃.
Store in cool, dry & dark place.
Protect from Light & moisture.
Dosage: As directed by the Physician.
Introduction to Remogliflozin + Vildagliptin + Metformin Tablets (Uses, Mechanism & Global Demand)
This triple combination is prescribed for Type 2 diabetes mellitus patients who require more than one agent to achieve optimal blood glucose control.
How Each Component Works
-
Remogliflozin Etabonate 100mg
An SGLT2 inhibitor that works by eliminating excess glucose through urine. It significantly lowers fasting and postprandial blood sugar levels. -
Vildagliptin 50mg
A DPP-4 inhibitor that increases incretin levels, stimulating insulin release and suppressing glucagon levels. -
Metformin Hydrochloride 500mg
Reduces glucose production in the liver, limits carbohydrate absorption, and increases insulin sensitivity.
Why This Combination Is Popular Worldwide
-
Provides comprehensive glucose control
-
Reduces fasting and post-meal blood sugar
-
Lowers risk of hypoglycemia (compared to sulfonylureas)
-
Helps improve glycemic HbA1c levels
-
Effective for overweight and obese diabetic patients
Common Side Effects (Usually Mild)
-
Nausea, diarrhea, vomiting
-
Dizziness, fatigue
-
Mild hypoglycemia when combined with other antidiabetics
-
Tremors
-
Constipation
Demand is rising rapidly in:
-
Asia (Bangladesh, Sri Lanka, Vietnam)
-
Middle East (UAE, Oman, Iraq)
-
Africa (Kenya, Nigeria, South Africa)
-
CIS & Latin America
This makes a WHO-GMP compliant manufacturer like Taj Pharma the preferred exporter globally.
Comprehensive Information for Importers, Exporters & Buyers
International buyers choose Taj Pharma because of their complete regulatory, manufacturing, and export-ready systems.
Regulatory Documentation Provided
Taj Pharma offers a full suite of global standard documentation:
-
WHO-GMP Certificate
-
COPP (Certificate of Pharmaceutical Product)
-
COA (Certificate of Analysis)
-
Stability Data (Zone II & III)
-
CTD / ACTD Dossier
-
Batch Manufacturing Records
-
Free Sale Certificate
-
MSDS
-
Packing List & Export Documentation
-
Product Master File
Custom Packaging & Labeling Options
-
Blister packs
-
Alu-Alu or Alu-PVC
-
Bottle packaging
-
Private labeling & OEM manufacturing
-
Custom branding with buyer’s logo
-
Country-specific language packs (Arabic, French, Portuguese, Spanish)
Shelf-Life, Storage & Dosage Form
-
Shelf-life: 24–36 months
-
Storage: Store below 25°C in a cool, dry place
-
Dosage Form: Film-coated tablets
-
Strength: 100mg + 50mg + 500mg
Export Certifications
Taj Pharma adheres to global quality standards, supported by:
-
WHO-GMP
-
ISO 9001:2015
-
EU-GMP aligned practices
-
GLP-certified testing laboratories
-
Periodic FDA-style audits
Target Export Markets
Taj Pharma exports this combination therapy to:
-
UAE
-
Iraq
-
Yemen
-
Kenya
-
Tanzania
-
South Africa
-
Nigeria
-
Ghana
-
Uzbekistan
-
Kazakhstan
-
Myanmar
-
Sri Lanka
-
Vietnam
-
Philippines
-
Nepal
-
Peru
-
Chile
-
Ecuador
-
Dominican Republic
-
Cambodia
This wide global reach highlights Taj Pharma’s international trust and regulatory readiness.
Why Taj Pharma is the Most Trusted Manufacturer & Exporter
1. State-of-the-Art WHO-GMP Manufacturing Facilities
Taj Pharma’s Vapi plant is equipped with:
-
Fully automated manufacturing lines
-
HEPA-controlled cleanrooms
-
Validated processes
-
In-house stability chambers
-
High-precision QC & QA systems
2. Affordable Pricing with Premium Quality
As India’s leading large-scale producer, Taj Pharma provides:
-
Competitive export pricing
-
Flexible MOQ
-
High-volume supply capability
-
Government tender pricing support
3. Exceptional Global Supply Chain Support
Taj Pharma ensures:
-
Fast export documentation
-
Timely dispatch
-
Temperature-controlled logistics
-
Support for product registration globally
4. Top 20 Exporting Countries
USA, UK, South Africa, Kenya, Nigeria, Ghana, Vietnam, Myanmar, Philippines, Bangladesh, Sri Lanka, Iraq, Yemen, Uzbekistan, Kazakhstan, Georgia, Peru, Bolivia, Ukraine, Cambodia
Technical Product Specification Table
| Parameter | Details |
|---|---|
| Product Name | Remogliflozin + Vildagliptin + Metformin Tablets |
| Strength | 100mg + 50mg + 500mg |
| Dosage Form | Film-Coated Tablet |
| Packaging | Alu-Alu / Alu-PVC |
| Manufacturer | Taj Pharma India |
| Certification | WHO-GMP, ISO 9001:2015 |
| Shelf Life | 24–36 months |
| Storage | Below 25°C, dry place |
| MOQ | 50,000 to 100,000 tablets |
| Indication | Type 2 Diabetes |
| Export Support | COPP, CTD Dossier, COA, Stability studies |
Call to Action
If you are an importer, distributor, wholesaler, tender participant, or PCD franchise seeker searching for a Remogliflozin Etabonate 100mg + Vildagliptin 50mg + Metformin Hydrochloride 500mg Tablets Manufacturer in India, Taj Pharma is your trusted partner.
📩 Contact Taj Pharma
Email: info@tajpharma.com
Website: https://www.tajpharma.com
Head Office: Mumbai, Maharashtra
Manufacturing Unit: Vapi, Gujarat
Partner with Taj Pharma for:
-
Bulk exports
-
Private label manufacturing
-
Hospital & government tenders
-
PCD pharma franchise opportunities
Top 20 FAQs
1. What is this triple combination used for?
It is used for comprehensive blood sugar control in Type 2 diabetes patients.
2. Is Taj Pharma a WHO-GMP manufacturer?
Yes, Taj Pharma is a certified WHO-GMP manufacturer in India.
3. Do you provide export documentation?
Yes, full CTD dossiers, COA, COPP, FSC, and regulatory support.
4. What makes this combination effective?
It targets glucose absorption, production, and excretion—delivering triple action control.
5. Are custom packaging and branding available?
Yes, OEM, private labeling, and multilingual packs are offered.
6. What are the common side effects?
Nausea, dizziness, diarrhea, trembling, fatigue.
7. Are stability data available?
Yes, Zone II and Zone III stability studies.
8. What is the shelf life?
24 to 36 months.
9. Can the product be shipped worldwide?
Yes, Taj Pharma exports to 40+ countries.
10. What are the packaging types?
Blister packs: Alu-Alu / Alu-PVC.
11. Is hypoglycemia possible?
Yes, especially when combined with alcohol or skipped meals.
12. Is private label export possible?
Absolutely—custom branding is supported.
13. What is the MOQ for export?
Generally 50,000–100,000 tablets.
14. Do you supply samples?
Samples are provided as per policy.
15. Are the tablets sugar-coated?
They are film-coated.
16. Is this approved for tender supply?
Yes, with complete regulatory documentation.
17. Do you support product registration abroad?
Yes, through comprehensive dossiers.
18. Are alternative strengths available?
Other metformin strengths may be manufactured on request.
19. How fast can orders be shipped?
Typically within 21–30 business days.
20. Why is Taj Pharma preferred globally?
Quality consistency, regulatory compliance, affordability, and global trust.






